Cargando…

Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study

Detalles Bibliográficos
Autores principales: Kevorkian, Jean-Philippe, Lopes, Amanda, Sène, Damien, Riveline, Jean-Pierre, Vandiedonck, Claire, Féron, Florine, Nassarmadji, Kladoum, Mouly, Stéphane, Mauvais-Jarvis, Franck, Gautier, Jean-François, Mégarbane, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871882/
https://www.ncbi.nlm.nih.gov/pubmed/33577902
http://dx.doi.org/10.1016/j.jinf.2021.02.008
_version_ 1783649100469633024
author Kevorkian, Jean-Philippe
Lopes, Amanda
Sène, Damien
Riveline, Jean-Pierre
Vandiedonck, Claire
Féron, Florine
Nassarmadji, Kladoum
Mouly, Stéphane
Mauvais-Jarvis, Franck
Gautier, Jean-François
Mégarbane, Bruno
author_facet Kevorkian, Jean-Philippe
Lopes, Amanda
Sène, Damien
Riveline, Jean-Pierre
Vandiedonck, Claire
Féron, Florine
Nassarmadji, Kladoum
Mouly, Stéphane
Mauvais-Jarvis, Franck
Gautier, Jean-François
Mégarbane, Bruno
author_sort Kevorkian, Jean-Philippe
collection PubMed
description
format Online
Article
Text
id pubmed-7871882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78718822021-02-10 Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study Kevorkian, Jean-Philippe Lopes, Amanda Sène, Damien Riveline, Jean-Pierre Vandiedonck, Claire Féron, Florine Nassarmadji, Kladoum Mouly, Stéphane Mauvais-Jarvis, Franck Gautier, Jean-François Mégarbane, Bruno J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-06 2021-02-09 /pmc/articles/PMC7871882/ /pubmed/33577902 http://dx.doi.org/10.1016/j.jinf.2021.02.008 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kevorkian, Jean-Philippe
Lopes, Amanda
Sène, Damien
Riveline, Jean-Pierre
Vandiedonck, Claire
Féron, Florine
Nassarmadji, Kladoum
Mouly, Stéphane
Mauvais-Jarvis, Franck
Gautier, Jean-François
Mégarbane, Bruno
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title_full Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title_fullStr Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title_full_unstemmed Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title_short Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
title_sort oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized covid-19 patients - the cocaa-cola cohort study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871882/
https://www.ncbi.nlm.nih.gov/pubmed/33577902
http://dx.doi.org/10.1016/j.jinf.2021.02.008
work_keys_str_mv AT kevorkianjeanphilippe oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT lopesamanda oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT senedamien oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT rivelinejeanpierre oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT vandiedonckclaire oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT feronflorine oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT nassarmadjikladoum oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT moulystephane oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT mauvaisjarvisfranck oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT gautierjeanfrancois oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy
AT megarbanebruno oralcorticoidaspirinanticoagulantcolchicineandfurosemidetoimprovetheoutcomeofhospitalizedcovid19patientsthecocaacolacohortstudy